MX2010004318A - Moduladores de la gamma-secretasa con enlaces de amina. - Google Patents
Moduladores de la gamma-secretasa con enlaces de amina.Info
- Publication number
- MX2010004318A MX2010004318A MX2010004318A MX2010004318A MX2010004318A MX 2010004318 A MX2010004318 A MX 2010004318A MX 2010004318 A MX2010004318 A MX 2010004318A MX 2010004318 A MX2010004318 A MX 2010004318A MX 2010004318 A MX2010004318 A MX 2010004318A
- Authority
- MX
- Mexico
- Prior art keywords
- sup
- secretase
- amine linked
- modulators
- linked modulators
- Prior art date
Links
- 150000001412 amines Chemical class 0.000 title 1
- 150000001875 compounds Chemical class 0.000 abstract 2
- 201000010099 disease Diseases 0.000 abstract 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 2
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
- C07C229/40—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino groups bound to carbon atoms of at least one six-membered aromatic ring and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
- C07C229/42—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino groups bound to carbon atoms of at least one six-membered aromatic ring and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton with carboxyl groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by saturated carbon chains
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
- C07C229/02—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
- C07C229/34—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton containing six-membered aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C255/00—Carboxylic acid nitriles
- C07C255/49—Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
- C07C255/58—Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton containing cyano groups and singly-bound nitrogen atoms, not being further bound to other hetero atoms, bound to the carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/08—Indoles; Hydrogenated indoles with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to carbon atoms of the hetero ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/72—Nitrogen atoms
- C07D213/74—Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/04—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to the ring carbon atoms
- C07D215/06—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to the ring carbon atoms having only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached to the ring nitrogen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/12—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/38—Nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
- C07D217/02—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines
- C07D217/04—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines with hydrocarbon or substituted hydrocarbon radicals attached to the ring nitrogen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2602/00—Systems containing two condensed rings
- C07C2602/02—Systems containing two condensed rings the rings having only two atoms in common
- C07C2602/04—One of the condensed rings being a six-membered aromatic ring
- C07C2602/10—One of the condensed rings being a six-membered aromatic ring the other ring being six-membered, e.g. tetraline
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Neurosurgery (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biomedical Technology (AREA)
- Medicinal Chemistry (AREA)
- Neurology (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Other In-Based Heterocyclic Compounds (AREA)
- Pyridine Compounds (AREA)
- Indole Compounds (AREA)
- Quinoline Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
La presente invenci?n se relaciona con compuestos de la F?rmula I como se muestra a continuaci?n, en donde las definiciones de A, X, Y, R1, R2, R3, R4, R5, R6, R7, R8 y R9 se proporcionan en la descripci?n. Los compuestos de la F?rmula I son ?tiles para el tratamiento de enfermedades asociadas con la actividad de la y-secretasa, que incluye la enfermedad de Alzheimer. (ver f?rmula (I).
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US98129307P | 2007-10-19 | 2007-10-19 | |
PCT/US2008/080270 WO2009052350A1 (en) | 2007-10-19 | 2008-10-17 | Amine linked modulators of y-secretase |
Publications (1)
Publication Number | Publication Date |
---|---|
MX2010004318A true MX2010004318A (es) | 2010-04-30 |
Family
ID=40090406
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2010004318A MX2010004318A (es) | 2007-10-19 | 2008-10-17 | Moduladores de la gamma-secretasa con enlaces de amina. |
Country Status (15)
Country | Link |
---|---|
US (1) | US8247610B2 (es) |
EP (1) | EP2212277B1 (es) |
JP (1) | JP5543354B2 (es) |
KR (1) | KR20100082351A (es) |
CN (1) | CN101903335A (es) |
AU (1) | AU2008312371B2 (es) |
BR (1) | BRPI0817837A2 (es) |
CA (1) | CA2703636A1 (es) |
CO (1) | CO6270315A2 (es) |
CR (1) | CR11450A (es) |
EA (1) | EA018862B1 (es) |
IL (1) | IL205041A (es) |
MX (1) | MX2010004318A (es) |
NI (1) | NI201000066A (es) |
WO (1) | WO2009052350A1 (es) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101896452B (zh) * | 2007-10-19 | 2013-07-31 | 詹森药业有限公司 | 连接有碳的γ-分泌酶调节剂 |
NZ584716A (en) * | 2007-10-19 | 2011-12-22 | Janssen Pharmaceutica Nv | PIPERIDINYL AND PIPERAZINYL MODULATORS OF gamma-SECRETASE |
Family Cites Families (22)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
BE790287A (fr) * | 1971-10-28 | 1973-04-19 | Delalande Sa | Acides pyrimidin-6yl acethydroxamiques, leur procede de preparation et leur application en therapeutique |
BE826017R (fr) * | 1974-03-19 | 1975-08-26 | Acides pyrimidin-6yl acethydroxamiques, leur procede de preparation et leur application en therapeutique | |
US4252951A (en) * | 1979-10-09 | 1981-02-24 | Eli Lilly And Company | Isolation of syn-7-(2-amino-4-thiazolyl)-(methoxyimino)acetamido-3-acetoxymethyl-3-cephem-4-carboxylic acid |
US5391817A (en) * | 1993-12-21 | 1995-02-21 | Bristol-Myers Squibb | Biaryl phospholipase A2 inhibitors |
US5877399A (en) * | 1994-01-27 | 1999-03-02 | Johns Hopkins University | Transgenic mice expressing APP-Swedish mutation develop progressive neurologic disease |
JP2003530437A (ja) * | 2000-04-13 | 2003-10-14 | マヨ ファウンデーション フォー メディカル エデュケーション アンド リサーチ | Aβ42低下物質 |
DE10131899A1 (de) | 2001-07-04 | 2003-02-27 | Boehringer Ingelheim Pharma | In vitro-Screening-Assay für gamma-Secretase |
WO2006004555A1 (en) | 2004-06-30 | 2006-01-12 | Paysetter Pte Ltd | System and method for facilitating transfer of physical money and/or credit |
DE102004033876B4 (de) | 2004-07-13 | 2009-01-15 | Christoph Kaesbohrer | Dreidimensionales Struktursystem |
GB0416508D0 (en) * | 2004-07-23 | 2004-08-25 | Merck Sharp & Dohme | Therapeutic agents |
EP1650183A1 (en) | 2004-10-21 | 2006-04-26 | Cellzome Ag | (Benzyloxy-biphenyl) acetic acids and derivatives thereof and their use in therapy |
US8110681B2 (en) * | 2006-03-17 | 2012-02-07 | The United States Of America As Represented By The Secretary, Department Of Health And Human Services | Compounds for the treatment of spinal muscular atrophy and other uses |
SI1849762T1 (sl) * | 2006-04-21 | 2009-12-31 | Cellzome Ltd | Substituirane bifenil karboksilne kisline in derivati le-teh |
PL1847524T3 (pl) | 2006-04-21 | 2010-03-31 | Cellzome Ltd | Pochodne terfenylu do leczenia choroby Alzheimera |
JP2009539880A (ja) * | 2006-06-09 | 2009-11-19 | アイコス コーポレイション | Dp−2アンタゴニストとしての置換フェニル酢酸 |
CN101490001A (zh) | 2006-06-09 | 2009-07-22 | Icos股份有限公司 | 用作dp-2拮抗剂的取代的苯乙酸 |
DK2215044T3 (da) * | 2007-10-17 | 2012-11-26 | Cellzome Ltd | Biphenylcarboxylsyrer og derivater deraf |
CN101896452B (zh) | 2007-10-19 | 2013-07-31 | 詹森药业有限公司 | 连接有碳的γ-分泌酶调节剂 |
BRPI0817789A2 (pt) * | 2007-10-19 | 2015-03-24 | Janssen Pharmaceutica Nv | Intermediários de moduladores de gama secretase (gsm) |
NZ584716A (en) | 2007-10-19 | 2011-12-22 | Janssen Pharmaceutica Nv | PIPERIDINYL AND PIPERAZINYL MODULATORS OF gamma-SECRETASE |
BRPI0817425A2 (pt) * | 2007-10-19 | 2015-06-16 | Janssen Pharmaceutica Nv | Moduladores de gama-secretase ligados à amida |
US7968725B2 (en) * | 2008-07-22 | 2011-06-28 | Janssen Pharmaceutica N.V. | Pyridinyl modulators of γ-secretase |
-
2008
- 2008-10-17 MX MX2010004318A patent/MX2010004318A/es active IP Right Grant
- 2008-10-17 EP EP08839840.9A patent/EP2212277B1/en active Active
- 2008-10-17 AU AU2008312371A patent/AU2008312371B2/en not_active Ceased
- 2008-10-17 KR KR1020107010872A patent/KR20100082351A/ko active IP Right Grant
- 2008-10-17 CN CN2008801215605A patent/CN101903335A/zh active Pending
- 2008-10-17 US US12/253,444 patent/US8247610B2/en not_active Expired - Fee Related
- 2008-10-17 EA EA201070498A patent/EA018862B1/ru not_active IP Right Cessation
- 2008-10-17 CA CA2703636A patent/CA2703636A1/en not_active Abandoned
- 2008-10-17 JP JP2010530134A patent/JP5543354B2/ja not_active Expired - Fee Related
- 2008-10-17 WO PCT/US2008/080270 patent/WO2009052350A1/en active Application Filing
- 2008-10-17 BR BRPI0817837-2A patent/BRPI0817837A2/pt not_active IP Right Cessation
-
2010
- 2010-04-13 IL IL205041A patent/IL205041A/en not_active IP Right Cessation
- 2010-04-16 NI NI201000066A patent/NI201000066A/es unknown
- 2010-04-30 CO CO10051584A patent/CO6270315A2/es not_active Application Discontinuation
- 2010-05-19 CR CR11450A patent/CR11450A/es not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
AU2008312371B2 (en) | 2013-06-20 |
KR20100082351A (ko) | 2010-07-16 |
CR11450A (es) | 2011-01-14 |
EP2212277B1 (en) | 2016-08-31 |
NI201000066A (es) | 2010-09-13 |
EP2212277A1 (en) | 2010-08-04 |
CO6270315A2 (es) | 2011-04-20 |
IL205041A0 (en) | 2010-11-30 |
US20090105300A1 (en) | 2009-04-23 |
CN101903335A (zh) | 2010-12-01 |
JP5543354B2 (ja) | 2014-07-09 |
BRPI0817837A2 (pt) | 2015-04-07 |
JP2011500722A (ja) | 2011-01-06 |
EA201070498A1 (ru) | 2010-10-29 |
CA2703636A1 (en) | 2009-04-23 |
US8247610B2 (en) | 2012-08-21 |
IL205041A (en) | 2015-01-29 |
EA018862B1 (ru) | 2013-11-29 |
WO2009052350A1 (en) | 2009-04-23 |
AU2008312371A1 (en) | 2009-04-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MY153971A (en) | Sulfonamides as trpm8 modulators | |
MX2012000973A (es) | Compuestos para la reduccion de produccion de beta- amiloide. | |
MY151348A (en) | Substituted n-phenyl-bipyrrolidine carboxamides and therapeutic use thereof | |
TW200630374A (en) | Thiazolyldihydroindazoles | |
HK1146054A1 (en) | Substituted n-phenyl-bipyrrolidine carboxamides and therapeutic use thereof | |
HK1146056A1 (en) | Substituted n-phenyl-bipyrrolidine ureas and therapeutic use thereof | |
TW200716152A (en) | Substituted 1,2-ethylendiamines, medicaments comprising said compound, their use and their method of manufacture | |
IL205045A0 (en) | Piperidinyl and piperazinyl modulators of ?? - secretase | |
MX2010009837A (es) | Tiazolil-dihidro-indazoles. | |
MX2010004310A (es) | Moduladores de gamma-secretasa con enlaces de carbono. | |
MX2010004308A (es) | Moduladores enlazados a amida gamma secretasa. | |
RS20080139A (en) | Imidazole coumpounds for the treatment of neurological disorders | |
WO2010011626A3 (en) | Pyridinyl modulators of ϒ-secretase | |
PT2234966E (pt) | Derivados de azetidinas, sua preparação e sua aplicação em terapia | |
MX2010004318A (es) | Moduladores de la gamma-secretasa con enlaces de amina. | |
MX2010004311A (es) | Productos intermedios de moduladores de gamma-secretasa. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG | Grant or registration |